Positive and negative predictive value

Last updated: November 01, 2022

Positive and negative predictive value

B1M2

B1M2

Fragile X syndrome
Turner syndrome
Turner syndrome: Year of the Zebra
Angelman syndrome
Prader-Willi syndrome
Miscellaneous genetic disorders: Pathology review
Gel electrophoresis and genetic testing
DNA mutations
Gene regulation
Oncogenes and tumor suppressor genes
Independent assortment of genes and linkage
Autosomal trisomies: Pathology review
Cellular structure and function
Nuclear structure
DNA structure
Cell cycle
DNA damage and repair
Mitosis and meiosis
Microtubule inhibitors
Karyotyping
DNA alkylating medications
Fluorescence in situ hybridization
Topoisomerase inhibitors
Anti-tumor antibiotics
Cytoskeleton and intracellular motility
Edwards syndrome (Trisomy 18)
Down syndrome (Trisomy 21)
Patau syndrome (Trisomy 13)
Klinefelter syndrome
Huntington disease
DNA synthesis inhibitors: Fluoroquinolones
DNA replication
Translation of mRNA
Transcription of DNA
Nucleotide metabolism
DNA synthesis inhibitors: Metronidazole
Gout
Lesch-Nyhan syndrome
Myotonic dystrophy
Ribonucleotide reductase inhibitors
Miscellaneous protein synthesis inhibitors
Purine and pyrimidine synthesis and metabolism disorders: Pathology review
Disorders of sex chromosomes: Pathology review
Williams syndrome
DiGeorge syndrome
Inheritance patterns
Human development week 3
Endoderm
Hedgehog signaling pathway
Development of the fetal membranes
Human development week 2
Miscarriage
Mesoderm
Ectoderm
Human development days 4-7
Human development days 1-4
Development of the placenta
Menstrual cycle
Pregnancy
Marfan syndrome
Hypertriglyceridemia
Hemophilia
Hemophilia: Year of the Zebra
Gaucher disease (NORD)
Phenylketonuria (NORD)
Ehlers-Danlos syndrome
Mendelian genetics and punnett squares
Hardy-Weinberg equilibrium
Approach to knee pain: Clinical sciences
Metaplasia and dysplasia
Breast cancer: Clinical
Colorectal polyps
Familial adenomatous polyposis
Colorectal cancer
Breast cancer
Chronic leukemia
Acute leukemia
Colorectal cancer: Clinical
Cushing syndrome
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Hypercalcemia
Respiratory distress syndrome: Pathology review
Sudden infant death syndrome
Environmental and chemical toxicities: Pathology review
Incidence and prevalence
Odds ratio
Relative and absolute risk
Positive and negative predictive value
Sensitivity and specificity
Test precision and accuracy
Case-control study
Cohort study
Cross sectional study

Transcript

Watch video only

Imagine that a person gets the results of a colon cancer screening test.

There are two possible scenarios - either the result is positive, indicating that they have colon cancer, or the result is negative, indicating they don’t have colon cancer.

At this point, the person may ask themselves, how worried should I be that it was a positive test result? Or, how reassured should I be that it was a negative test result?

Each test has a positive predictive value, or PPV, which is the probability that people with a positive test result truly have the outcome, and a negative predictive value, or NPV, which is the probability that people with a negative test result truly don’t have the outcome.

Let’s take an example to show how it’s possible to measure a test’s predictive value.

Let’s say that we recruit 1000 people - 100 people with colon cancer and 900 people without colon cancer - and then we give them all the same screening test.

That way we can see how many people with positive results actually have colon cancer and how many people with negative results actually don’t have colon cancer.

We can organize the results using a 2 by 2 table, where the true disease status of the individual is on the top of the box, and the results of the screening test are on the side, and each of the cells is labeled a, b, c, or d.

A true positive would be a person who gets a positive test result and has colon cancer.

A true negative would be a person who gets a negative test result and doesn’t have colon cancer.

A false positive would be a person who gets a positive test result even though they don’t have colon cancer.

And a false negative would be a person who gets a negative test result even though they have colon cancer.

To calculate the positive predictive value, we divide the number of true positives by the total number of people who tested positive - so cell a divided by the sum of cell a and b.

A test with a perfect positive predictive value would have 100 true positives in cell a, because the test would correctly identify everyone who has colon cancer, and zero false positives in cell b.

To calculate negative predictive value, we divide the number of true negatives by the total number of people who tested negative - so cell d divided by the sum of cell c and d.

A test with perfect specificity would have 900 true negatives in cell d, because the test would correctly identify everyone who doesn’t have colon cancer, and zero false negatives, in cell c.

But no test is 100% perfect, so let’s say that cell a contains 90 true positives, cell b contains 50 false positives, cell c contains 30 false negatives, and cell d contains 850 true negatives.

In this situation, the positive predictive value would be 64%, because there are 90 people who are true positives - in cell a - and 140 people who tested positively - cell a plus cell b.

In other words, 64% of people who test positively will actually have colon cancer, while the other 36% of people who test positively will not have colon cancer.

The negative predictive value would be 97%, because there are 850 people - in cell d - who are true negatives and 880 people who tested negatively- cell b plus cell d.

In other words, 97% of people who test negatively will actually not have colon cancer, while the other 3% of people who test negatively will have colon cancer.

Predictive values are commonly confused with sensitivity and specificity.

A test with high sensitivity will correctly identify most people who have the condition, and a test with high specificity will correctly identify most people who don’t have the outcome.

The main difference between validity and predictive value is that sensitivity and specificity are fixed characteristics of a test.

On the other hand, predictive values are affected by the prevalence of the outcome.

To understand this better, let’s follow another example.

So, imagine we now want to test for colon cancer in a group of 10,000 teenagers.

Colon cancer is rare for teenagers, so let’s say the prevalence is only about 1%, in reality, it would be far lower, but this makes the numbers easier to follow.

Key Takeaways

Positive predictive value (PPV) is a measure of the accuracy of a positive test result in a diagnostic test, calculated by dividing the number of true positives by the sum of true positives and false positives. It is used to quantify the likelihood that a person with a positive test result actually has the condition the test is designed to detect.

On the other hand, there is negative predictive value (NPV), which is a measure of the accuracy of a negative test result in a diagnostic test, calculated by dividing the number of true negatives by the sum of true negatives and false negatives. It is used to quantify the likelihood that a person with a negative test result does not have the condition the test is designed to detect.